+ Larger Font | - Smaller Font
Share


Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Scientific News Boston Scientific Cancels $230m Stent Deal After Regulators Erect Barriers To Acquisition is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.
Search RobinsPost News & Noticias


Scientific News Boston Scientific Cancels $230m Stent Deal After Regulators Erect Barriers To Acquisition | RobinsPost News & Noticias

Boston Scientific scraps $230M plan to buy Korean medical device maker


In June 2022, Boston Scientific (BSX) announced a $230M deal with Synergy Innovation to purchase its majority stake of ~64% in M.I.Tech, a maker of medical devices for endoscopic and urologic ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus